CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenues
Total revenues	$ 47,274,162	$ 38,033,667
Cost of revenues	23,137,997	17,079,069
Gross profit	24,136,165	20,954,598
Operating expenses
Selling, general and administrative	20,276,842	17,700,651
Depreciation and amortization	4,026,578	2,909,612
Total operating expenses	24,303,420	20,610,263
(Loss) income from operations	(167,255)	344,335
Other income
Interest income, net	2,531,071	790,917
Income before income tax (benefit) provision	2,363,816	1,135,252
Income tax (benefit) provision	(4,094,911)	107,477
Net income	$ 6,458,727	$ 1,027,775
Income per share
Basic	$ 0.12	$ 0.02
Diluted	$ 0.12	$ 0.02
Weighted average common shares
Basic	52,487,840	52,048,127
Diluted	54,162,485	52,933,255
Plasma Industry [Member]
Revenues
Total revenues	$ 41,951,659	$ 34,737,640
Pharmaceutical industry [Member]
Revenues
Total revenues	4,051,037	3,007,140
Other Revenue [Member]
Revenues
Total revenues	$ 1,271,466	$ 288,887